News|Articles|January 22, 2026
The Journey from Bench to Patient: Reach First-in-Human to Proof of Concept Trials with Speed, Safety, and Certainty
Author(s)Quotient Sciences
Partnering with an experienced first-in-human specialist such as Quotient Sciences is the key to navigating early development with confidence. Through our work with small molecules and biologics, we provide the expertise, infrastructure, and agility needed to move your novel therapy forward, faster.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
2
Accelerate Clinical Trials with AI-Enhanced Financial Management
3
Interdependence-Aware Attribution in Real-World Evidence: A Case Study on Semaglutide Weight Loss Outcomes
4
SCOPE Summit 2026: How Sponsors Are Prioritizing AI Adoption Across Clinical Trials
5